Bevacizumab Injection recalled over sterility concerns
- Recall date
- August 29, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Fagron Compounding Services recalls bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 87…
- Recall number
- D-0646-2025
- FDA classification
- Class II
- Brand / firm
- Fagron Compounding Services
- Sold / distributed
- USA nationwide.
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 8710 E 34th St N. Wichita, KS 67226
Get recall alerts
Free email alert whenever Fagron Compounding Services has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Fagron Compounding Services